142 related articles for article (PubMed ID: 12943817)
1. Glutathion S transferase pi indicates chemotherapy resistance in breast cancer.
Su F; Hu X; Jia W; Gong C; Song E; Hamar P
J Surg Res; 2003 Jul; 113(1):102-8. PubMed ID: 12943817
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy.
Hsu CH; Chen CL; Hong RL; Chen KL; Lin JF; Cheng AL
Oncology; 2002; 62(4):305-12. PubMed ID: 12138237
[TBL] [Abstract][Full Text] [Related]
3. Value of glutathion-S transferase pi as a prognostic factor in epithelial ovarian carcinoma.
Saip P; Tuzlali S; Demir K; Sakar B; Yavuz E; Berkman S; Bengisu E; Topuz E
Eur J Gynaecol Oncol; 2005; 26(1):90-4. PubMed ID: 15755010
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase pi.
Goto S; Ihara Y; Urata Y; Izumi S; Abe K; Koji T; Kondo T
FASEB J; 2001 Dec; 15(14):2702-14. PubMed ID: 11726546
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
Huang J; Tan PH; Thiyagarajan J; Bay BH
Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
[TBL] [Abstract][Full Text] [Related]
6. Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma.
Konishi I; Nanbu K; Mandai M; Tsuruta Y; Kataoka N; Nagata Y; Mori T
Gynecol Oncol; 1998 Sep; 70(3):365-71. PubMed ID: 9790789
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.
Shiga H; Heath EI; Rasmussen AA; Trock B; Johnston PG; Forastiere AA; Langmacher M; Baylor A; Lee M; Cullen KJ
Clin Cancer Res; 1999 Dec; 5(12):4097-104. PubMed ID: 10632346
[TBL] [Abstract][Full Text] [Related]
8. NBDHEX re-sensitizes adriamycin-resistant breast cancer by inhibiting glutathione S-transferase pi.
Sha H; Zou R; Lu Y; Gan Y; Ma R; Feng J; Chen D
Cancer Med; 2023 Mar; 12(5):5833-5845. PubMed ID: 36266920
[TBL] [Abstract][Full Text] [Related]
9. Glutathione transferase pi (GSTpi) expression in breast cancer: an immunohistochemical and molecular study.
Jardim BV; Moschetta MG; Gelaleti GB; Leonel C; Regiani VR; de Santi Neto D; Bordin-Junior NA; Perea SA; Zuccari DA
Acta Histochem; 2012 Sep; 114(5):510-7. PubMed ID: 22000861
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of drug resistance-associated proteins in ovarian carcinomas.
Mayr D; Pannekamp U; Baretton GB; Gropp M; Meier W; Flens MJ; Scheper R; Diebold J
Pathol Res Pract; 2000; 196(7):469-75. PubMed ID: 10926324
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells.
Goto S; Iida T; Cho S; Oka M; Kohno S; Kondo T
Free Radic Res; 1999 Dec; 31(6):549-58. PubMed ID: 10630679
[TBL] [Abstract][Full Text] [Related]
12. Dual effects of glutathione-S-transferase pi on As2O3 action in prostate cancer cells: enhancement of growth inhibition and inhibition of apoptosis.
Lu M; Xia L; Luo D; Waxman S; Jing Y
Oncogene; 2004 May; 23(22):3945-52. PubMed ID: 15007384
[TBL] [Abstract][Full Text] [Related]
13. Nuclear glutathione S-transferase pi prevents apoptosis by reducing the oxidative stress-induced formation of exocyclic DNA products.
Kamada K; Goto S; Okunaga T; Ihara Y; Tsuji K; Kawai Y; Uchida K; Osawa T; Matsuo T; Nagata I; Kondo T
Free Radic Biol Med; 2004 Dec; 37(11):1875-84. PubMed ID: 15528046
[TBL] [Abstract][Full Text] [Related]
14. Significance of nuclear glutathione S-transferase pi in resistance to anti-cancer drugs.
Goto S; Kamada K; Soh Y; Ihara Y; Kondo T
Jpn J Cancer Res; 2002 Sep; 93(9):1047-56. PubMed ID: 12359059
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of GSTpi expression by tryptanthrin contributing to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis.
Yu ST; Chen TM; Chern JW; Tseng SY; Chen YH
Anticancer Drugs; 2009 Jun; 20(5):382-8. PubMed ID: 19318911
[TBL] [Abstract][Full Text] [Related]
17. Effects of geranyl-phloroacetophenone on the induction of apoptosis and chemosensitization of adriamycin-resistant MCF-7 human breast cancer cells.
Cho MY; Park SY; Park S; Lee YR; Kwak MK; Kim JA
Arch Pharm Res; 2012 May; 35(5):911-9. PubMed ID: 22644859
[TBL] [Abstract][Full Text] [Related]
18. Influence of glutathione S-transferase pi and p53 expression on tumor frequency and spectrum in mice.
Gate L; Majumdar RS; Lunk A; Tew KD
Int J Cancer; 2005 Jan; 113(1):29-35. PubMed ID: 15386426
[TBL] [Abstract][Full Text] [Related]
19. Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves.
Nishiyama M; Yamamoto W; Park JS; Okamoto R; Hanaoka H; Takano H; Saito N; Matsukawa M; Shirasaka T; Kurihara M
Clin Cancer Res; 1999 Sep; 5(9):2620-8. PubMed ID: 10499641
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways.
Ruscoe JE; Rosario LA; Wang T; Gaté L; Arifoglu P; Wolf CR; Henderson CJ; Ronai Z; Tew KD
J Pharmacol Exp Ther; 2001 Jul; 298(1):339-45. PubMed ID: 11408560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]